Xiyuan P. Zhou

Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Dupilumab Remodels the Skin and Gut Microbiomes in Children With Moderate-To-Severe Atopic Dermatitis: A Pilot Longitudinal Study.

Dupilumab Remodels the Skin and Gut Microbiomes in Children With Moderate-To-Severe Atopic Dermatitis: A Pilot Longitudinal Study.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: June 20, 2026

IL-4Rα antagonist (Stapokibart) in refractory palmoplantar pustulosis: a case report and literature review of Th2-targeted therapies.

IL-4Rα antagonist (Stapokibart) in refractory palmoplantar pustulosis: a case report and literature review of Th2-targeted therapies.

Journal: Frontiers in immunology

Published: April 09, 2026

Silencing SLC52A2 promotes tertiary lymphoid structure formation and inhibits IL-17 pathway to ameliorate melanoma progression.

Silencing SLC52A2 promotes tertiary lymphoid structure formation and inhibits IL-17 pathway to ameliorate melanoma progression.

Journal: Apoptosis : an international journal on programmed cell death

Published: April 07, 2026

Driver Mutation Subtypes Differentially Shape Immune Evasion Landscapes in Melanoma: An AI-Driven Inflammatory Pathway Model Implicating CCNE1.

Driver Mutation Subtypes Differentially Shape Immune Evasion Landscapes in Melanoma: An AI-Driven Inflammatory Pathway Model Implicating CCNE1.

Journal: Human mutation

Published: April 04, 2026

Efficacy and Predictors of Low-Dose Abrocitinib in Chinese Adults with Moderate-to-Severe Atopic Dermatitis: A Prospective Study.

Efficacy and Predictors of Low-Dose Abrocitinib in Chinese Adults with Moderate-to-Severe Atopic Dermatitis: A Prospective Study.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: October 03, 2025

Microbiome dysbiosis and therapeutic restoration in atopic dermatitis.

Microbiome dysbiosis and therapeutic restoration in atopic dermatitis.

Journal: Frontiers in cellular and infection microbiology

Published: August 27, 2025

Nail dystrophy successfully treated with dupilumab in pediatric atopic dermatitis: case series and literature review.

Nail dystrophy successfully treated with dupilumab in pediatric atopic dermatitis: case series and literature review.

Journal: Frontiers in immunology

Published: July 17, 2025

Dupilumab relieves pruritus both in uremic pruritus and in atopic dermatitis with chronic kidney disease: a retrospective real-world study.

Dupilumab relieves pruritus both in uremic pruritus and in atopic dermatitis with chronic kidney disease: a retrospective real-world study.

Journal: Frontiers in medicine

Published: May 13, 2025

Case Report: Omalizumab-associated hair loss: a case of eyebrow alopecia areata, literature review and FAERS database analysis.

Case Report: Omalizumab-associated hair loss: a case of eyebrow alopecia areata, literature review and FAERS database analysis.

Journal: Frontiers in medicine

Published: April 26, 2025

Atopic dermatitis in amyotrophic lateral sclerosis successfully treated by dupilumab: A case report.

Atopic dermatitis in amyotrophic lateral sclerosis successfully treated by dupilumab: A case report.

Journal: Medicine

Published: April 19, 2025

Probiotics supplements for the prevention of atopic dermatitis in children: an umbrella review.

Probiotics supplements for the prevention of atopic dermatitis in children: an umbrella review.

Journal: Frontiers in nutrition

Published: March 04, 2025

Efficacy and Safety of Dupilumab in Treating Intrinsic and Extrinsic Atopic Dermatitis in Older Patients With and Without Atopic Comorbidities: A Retrospective Study.

Efficacy and Safety of Dupilumab in Treating Intrinsic and Extrinsic Atopic Dermatitis in Older Patients With and Without Atopic Comorbidities: A Retrospective Study.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: February 12, 2025

Showing 1-12 of 20

Last Updated: 09/26/2026